Date:7/30/2009

1% Imaging 12,906 11,016 - - 12,906 11,016 17% 17% Services (CDAS) 4,123 4,789 - - 4,123 4,789 (14%) (14%) ----- ----- ---- ------ ------ ------ Total revenue $32,111 $34,031 $ - $(3,299) $32,111 $30,732 (6%) 4% ------- ------- ---- ------- ------- ------- Non-GAAP Revenues for the Six Months Ended June 30, 2009 Six Months Ended June 30, --------------------------- Non-GAAP GAAP Adjustments(1) Non-GAAP ------------ -------------- ------------- (in thousands) Non- GAAP GAAP 2009 2008 2009 2008 2009 2008 % Chg % Chg ---- ---- ---- ---- ---- ---- ---- ---- Research $28,603 $33,205 $(343)$(6,192) $28,260 $27,013 (14%) 5% Imaging 23,647 20,790 - - 23,647 20,790 14% 14% Services (CDAS) 8,333 9,323 - - 8,333 9,323 (11%) (11%) ----- ----- ---- ----- ------ ----- Total revenue $60,583 $63,318 $(343) $(6,192)$60,240 $57,126 (4%) 5% ------- ------- --- ------- ------- ------- (1) For purposes of comparing growth rates for each of the three principal areas of our business, the above non-GAAP table reconciliations exclude revenues related to the PDQ and AutoTrace product lines divested in November 2008. The $343 of 2009 revenue included remaining first quarter revenues associated with the AutoTrace product lines. The Company anticipates no further revenue f
'/>"/>

SOURCE Caliper Life Sciences, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
2. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
3. Caliper Life Sciences to Webcast Investor Session of Open House
4. Caliper Life Sciences Reports First Quarter 2009 Results
5. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
6. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
7. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
8. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
9. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
11. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line